CytRx Corp. buy melinda
Start price
13.06.17
/
50%
€3.13
Target price
22.06.17
€3.79
Performance (%)
21.80%
End price
22.06.17
€3.82
Summary
This prediction ended on 22.06.17 with a price of €3.82. The BUY prediction by melinda finished with a performance of 21.80%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | -1,86 % | -1,62 % | 0,64 % | 51,03 % |
| iShares Nasdaq 100 | -3,32 % | 3,32 % | 32,00 % | 86,51 % |
| iShares Nikkei 225® | -2,30 % | 3,44 % | 51,01 % | 58,81 % |
| iShares S&P 500 | -1,31 % | 2,44 % | 23,01 % | 65,41 % |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
